14-day Premium Trial Subscription Sign Up For FreeGet Free

$0.48 (0%)

Volume: 1k

Closed: Jan 21, 2022

Hollow Logo Score: -4.543

Acura Pharmaceuticals Stock Forecast

$0.48 (0%)

Volume: 1k

Closed: Jan 21, 2022

Score Hollow Logo -4.543

Acura Pharmaceuticals Company Profile

616 N. North Court

Palatine IL 60067

847 705 7709



Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE